Aqtual

Founded in Hayward, California, Aqtual is a biotechnology diagnostics platform focused on revolutionizing chronic disease and oncology management. The company's core mission is to bridge the translational gap between groundbreaking research and practical healthcare solutions. Aqtual offers advanced diagnostic tools and healthcare solutions, leveraging proprietary biochemistry, novel technology, and data science to address some of the costliest disease areas, including rheumatoid arthritis.

Aqtual has garnered attention for its innovative approach to precision medicine, with a team of experts in biochemistry and technology driving its mission forward. The company has made significant strides in developing a comprehensive catalog of disease-specific diagnostics. Notable achievements include partnerships with leading healthcare institutions and recognition in scientific publications. Aqtual's impact lies in its potential to transform chronic disease management, making cutting-edge research accessible and actionable in clinical settings.